• PDF: Delivered by email within 12 to 48 hours of placing the order (Mon-Fri) UK business hours
  • PRINT/CD-ROM: Contact us for delivery details

China Dermatosis Drug Market Report
The Chinese Hospital Cancer Drug Utilization

China Dermatosis Drug Market Report The Chinese Hospital Cancer Drug Utilization

Dermatosis diseases are common diseases in China with high incidence and recurrence rates. The dermatosis disease rate is about 1.23%, meaning that there are about 160 million Chinese dermatosis patients. Dermatosis drugs are ranked as the No. 3 best selling drug category (by retail sales volume) in China. There are more than 600 dermatosis drugs for external use in the Chinese drug retail market. The market size of the Chinese dermatosis drug market in 2007 is about RMB 9.718 billion (USD 1.39 billion at 7:1 exchange rate), with a same period growth of 16.73%.

The No.1 Company in the Chinese dermatosis drug market has changed hands in the last three years. Chongqing Huabang was No.1 in 2005, Novartis took over in 2006 and Chongqing Huabang re-gained the title in 2007. The multinational pharmaceutical companies (MNCs) and joint-ventures are dominating the Chinese dermatosis drug market. Eight of the top 10 pharmaceutical companies are either MNCs or JVs. Only two Chinese companies are among the top 10 in 2007.

This report has systemically analyzed the Chinese dermatosis drug market. All market estimates of drug utilization in China are based on hospital drug prescription and drug purchasing data from the hospital data monitor system that the China Nan Fang Institute has developed and maintained (Nan Fang Institute is a direct subsidiary of the Chinese State Food and Drug Administration, the SFDA). Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, Xian, Shenyang, Harbin and Zhengzhou, covering significant percentages (20-60%) of all hospital beds in these regions.

Market shares from all major players (MNCs and Chinese pharmaceutical companies) and major dermatosis products are analyzed systemically based on data from the Chinese hospitals. The comprehensive hospital utilization data present a clear picture of the competition landscape of Chinese dermatosis drug market and the market potential for your company's product(s) that already marketed in China or for the products that you are planning to bring to the China market.
This China Dermatosis Drug Market Report has been a Must Have reference for decision makers in pharmaceutical companies, medical device companies, healthcare investing companies and healthcare consulting companies. These unique drug prescription and utilization data can provide valuable information for new product development, marketing and strategic planning functions for pharmaceutical companies.

Compared to expensive customized drug reports in China, this multi-client report provides significant savings and great cost/benefit to you.

  • The Top 20 Pharmaceutical Companies In The Chinese Dermatosis Drug Market 2007 (At Least Greater 1.17% Of The China Dermatosis Drug Market Shares)
  • Methodology for the Annual China Drug Market Reports
  • Key Drug Data For Each of These 18 Therapeutic Areas in China
  • List of Annual China Drug Market Reports 2008
    • Prologue
  • Chapter I: Summary of Dermatosis Drugs
    • Section 1: Current Clinical Utilization of Dermatosis Drugs in China
      • 1Major Anti-fungus Dermatosis Drugs
      • 2Major Types of Cortical Hormone Dermatosis Drugs
      • 3Major Dermatosis Drugs for Infectious Dermatosis and Major Disinfectants
      • 4Major Dermatosis Drugs for Psoriasis Treatment
    • Section 2: Classifications of Dermatosis drugs
      • 1Systemic Drug
      • 2External Treatment of Dermatosis Diseases
      • 3Physical Therapy for Dermatosis Diseases
  • Chapter II: Summary of The Dermatosis Drug Market
    • Section 1: Global Market of Dermatosis Drugs
      • 1Forecast of the Allergic Dermatitis Market Healthcare Consulting China Focus
      • 2Forecast of the US Psoriasis Drug Market
      • 3Global Market for Burn Treatment Drugs Surpassed USD 1.5 billion
    • Section 2: The Chinese Market of Dermatosis Drugs
    • Section 3: Market Shares of Dermatosis Drug Categories in China
    • Section 4: Market Shares of the Top 20 Dermatosis Drugs in China 2005-2007
    • Section 5: Market Shares of the Top 20 Manufacturers in the Chinese Dermatosis Drug Market 2005-2007
    • Section 6: Growth Rates of the Top 20 Dermatosis Drugs 2006-2007
    • Section 7: Market Potentials of Key Dermatosis Drugs in China
  • Chapter III: Market Sizes and Growths of Key Dermatosis Drugs in China
    • Section 1: Top 5 Dermatosis Drugs in Each Category (11 categories)
    • Section 2: Top 10 Best Selling Brand Dermatosis Drugs 2006-2007
      • 1Market Shares, Market Sizes and Manufacturers of Terbinafine
      • 2Market Shares, Market Sizes and Manufacturers of Mometasone
      • 3Market Shares, Market Sizes and Manufacturers of Povidone Iodide
      • 4Market Shares, Market Sizes and Manufacturers of Econazole
      • 5Market Shares, Market Sizes and Manufacturers of Halometasone (Halometasone/Triclosan)
      • 6Market Shares, Market Sizes and Manufacturers of Hydrocortisone Butyrate
      • 7Market Shares, Market Sizes and Manufacturers of Miconazole Nitrate
      • 8Market Shares, Market Sizes and Manufacturers of Mupirocin
      • 9Market Shares, Market Sizes and Manufacturers of Viaminate (Viaminate/vitaminE)
      • 10Market Shares, Market Sizes and Manufacturers of Calcipotriol Healthcare Consulting China Focus
  • Chapter IV: List of Brand Names, Generic Names, Formula & Manufacturers of Dermatosis Drugs in China
  • Chapter V: Dermatosis Drugs on the National Healthcare Insurance Coverage List
    • Section 1: Dermatosis Drugs on the National Basic Healthcare Insuracne List
      • 1Chemical Dermatosis Drugs on the National Basic Healthcare Insurance List
      • 2Traditional Chinese Medicine (TCM) Dermatosis Drugs on the National Basic Healthcare Insurance List
  • Chapter VI: R & D of Dermatosis Drugs
    • Section 1: New Dermatosis Drugs Approved in 2007
    • Section 2: New Dermatosis Drugs under Development
      • 1Ustekinumab
      • 2Enbrel
    • Section 3: Advancement of Dermatology Study in China
      • 1Transition from the Traditional Dermatology to Modern Dermatology
      • 2The Invention of Local Immunomodulator
      • 3Biologics for Psoriasis Treatment
      • 4Photo-therapy - Ultraviolet Radiation
      • 5Genetic Mutation Studies on the Genetic Dermatosis Diseases
      • 6Breakthrough in the Understanding of the Disease Development Mechanism of Paraneoplastic Pemphigus
      • 7Development of Photo Sensitizer
      • 8Anti-fungal Drugs
      • 9Laser Cosmetic Technology Healthcare Consulting China Focus
  • Exhibitions
    • Table 1: Commmon Corticosteroid Drugs and Dosages
    • Table 2: Common Antihistamine Drugs (H2 Receptor Antagonist)
    • Table 3: Commmon Corticosteroid Drugs and Dosages
    • Table 4: Market Shares of Dermatosis Drugs by Category 2002-2007
    • Table 5: Market Shares of Key Dermatosis Drugs in China 2005-2007
    • Table 6: Market Shares of the Top 20 Manufacturers in the Chinese Dermatosis Drug Market 2005-2007
    • Table 7: Market Share Growths of Key Dermatosis Drugs 2005-2007
    • Table 8: Top 5 Dermatosis Drugs by Category (By Sales Revenue) in 2006
    • Table 9: Top 5 Dermatosis Drugs by Category (By Sales Revenue) in 2007
    • Table 10: Market Shares and Manufacturers of Terbinafine 2005-2007
    • Table 11: Market Sizes and Manufacturers of Terbinafine 2006-2007
    • Table 12: Market Shares and Manufacturers of Mometasone 2005-2007
    • Table 13: Market Sizes and Manufacturers of Mometasone 2006-2007
    • Table 14: Market Shares and Manufacturers of Povidone Iodide 2005-2007
    • Table 15: Market Sizes and Manufacturers of Povidone Iodide 2006-2007
    • Table 16: Market Shares and Manufacturers of Econazole 2005-2007
    • Table 17: Market Sizes and Manufacturers of Econazole 2006-2007
    • Table 18: Market Shares and Manufacturers of Halometasone and Its Compound Preparations 2005-2007
    • Table 19: Market Sizes and Manufacturers of Halometasone and Its Compound Preparations 2006-2007 Healthcare Consulting China Focus
    • Table 20: Market Shares and Manufacturers of Miconazole Nitrate 2005-2007
    • Table 21: Market Sizes and Manufacturers of Miconazole Nitrate 2006-2007
    • Table 22: Market Sizes and Manufacturers of Viaminate 2005-2007
    • Table 23: Market Sizes and Manufacturers of Viaminate 2006-2007
    • Table 24: Brand Names, Generic Names, Formulas and Manufacturers of Dermatosis Drugs in China
    • Table 25: Chemical Dermatosis Drugs on the National Basic Healthcare Insurance List
    • Table 26: Traditional Chinese Medicine (TCM) Dermatosis Drugs on the National Basic Healthcare Insurance List
    • Table 27: New Dermatosis Drugs Approved in 2007
    • Table A: Hospital Coverage for the Monitoring and Tracking of Drug Prescription and Purchasing Data in China (Nan Fang Institute)
    • Figure 1: Market Sizes and Growth Rates of the Chinese Dermatosis Drug Market 2002-2007
    • Figure 2: Market Sizes and Sales Growths of Oral vsExternal Use Dermatosis Drugs 2002-2007
    • Figure 3: Market Potential of Key Dermatosis Drugs
    • Figure 4: Market Shares of the Top 10 Dermatosis Drugs in China 2006
    • Figure 5: Market Shares of the Top 10 Dermatosis Drugs in China 2007
  • The Top 20 Pharmaceutical Companies In The Chinese Dermatosis Drug Market 2007 (At Least Greater Than 1.17% Of The China Dermatosis Drug Market Shares)
    • Chongqing Huabang
    • Novartis
    • Xian-Janssen
    • Daiichi Seiyaku
    • Tianjin Pharmaceutical
    • Hong Kong Bright Future
    • Healthcare Consulting China Focus
    • Schering-Plough China
    • Tianjin SmithKline & French Laboratories Ltd
    • Shandong Qilu
    • LEO Pharmaceutical
    • Laboratories Galderma S.A
    • Shanghai Likang
    • Shanghai Xinyi
    • Luitpold-Werk, Chemisch-Pharma, Fabrik
    • Bayer
    • Jiangsu Jichuan
    • Teijin Limited
    • Sichuan Dikang
    • Zhejiang Hangzhou Yishute
    • GSK
+44 20 8816 8548

Ask a question about China Dermatosis Drug Market Report

Enter the characters you see in the picture below
Captcha